Results 91 to 100 of about 125,177 (307)

The role of EBV-encoded microRNAs in B cell differentiation [PDF]

open access: yes, 2012
Epstein Barr virus (EBV) is a common γ-herpes virus, infecting approximately 90% of the world‟s population. It is also one of the first known viruses known to be oncogenic, and is associated with a number of tumour types, primarily lymphomas.\ud \ud ...
Ross, Nathan Arlen
core  

Comparison of EBER flow FISH results from two facilities

open access: yesCytometry Part B: Clinical Cytometry, EarlyView.
Abstract Epstein–Barr virus (EBV) primarily infects B cells but can occasionally target T and/or NK cells, leading to chronic active EBV disease or EBV‐associated hemophagocytic lymphohistiocytosis, which are often difficult to treat. EBV‐associated diseases exhibit a wide range of phenotypes.
Madoka Nishimura   +13 more
wiley   +1 more source

EPSTEIN-BARR VIRUS-DRIVEN LYMPHOMAGENESIS IN THE CONTEXT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION

open access: yesFrontiers in Microbiology, 2013
Epstein–Barr Virus (EBV) is a ubiquitous human γ-herpes virus which establishes a life-long asymptomatic infection in immunocompetent hosts. In HIV-1 infected patients, the impaired immunosurveillance against EBV may favor the development of EBV-related ...
Maria Raffaella ePetrara   +5 more
doaj   +1 more source

EBV and human cancer [PDF]

open access: yesExperimental & Molecular Medicine, 2015
Epstein–Barr virus (EBV) was the first virus shown to cause cancer in humans and is associated with a wide range of human cancers originating from epithelial cells, lymphocytes and mesenchymal cells. EBV-associated neoplasms affect both immune-competent hosts and immune-compromized patients who have received an organ transplant or who exhibit ...
openaire   +2 more sources

Head and Neck Lymph Node Metastases From Cancer of Unknown Primary: Outcomes From p16‐Guided Mucosal Radiotherapy

open access: yesHead &Neck, EarlyView.
ABSTRACT Background The AJCC 8th edition distinguishes p16‐positive oropharyngeal head and neck carcinoma of unknown primary (HNCUP) due to its superior prognosis. However, standardized radiation volume guidelines are lacking. This study evaluates the safety of p16‐guided mucosal volume reduction.
Philippe Harris   +16 more
wiley   +1 more source

Comparative Analysis of Epstein-Barr Virus (Ebv) Latent Gene and Microrna Sequences among AKATA, B95.8, AG876 And GD1 EBV Genomes

open access: yes, 2010
Akata cell line is an Epstein-Barr virus (EBV)-producing line established from a Japanese patient with EBV-positive Burkitt lymphoma. It is extensively used in EBV-related studies in the published literature. Yet the existing DNA sequences of the Akata
Kwok, H, Chiang, AKS
core  

EBV-DNA in peripheral blood of mice inoculated with LCLs.

open access: yes
The EBV copy number in peripheral blood of mice inoculated with LCLs-WT and LCLs-dBNRF1 was quantified by qPCR analysis at the indicated time points. (TIFF)
Hitoshi Kiyoi (4458919)   +9 more
core   +1 more source

Pattern of Failure in Nasopharyngeal Carcinoma After Radiotherapy in a Low‐Incidence Population: A DAHANCA Study

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Nasopharyngeal carcinoma (NPC) is uncommon in many populations. Most existing clinical evidence comes from endemic areas, where Epstein–Barr virus (EBV)‐associated subtypes predominate. We analyzed patterns of failure in a population‐based cohort from Denmark, a low‐incidence setting.
Anne Marie Lindegaard   +14 more
wiley   +1 more source

Ebna-1 Sequence Variations Reflect Active Ebv Replication and Disease Status or Quiescent Latency in Lymphocytes

open access: yes, 2009
EBV infects most of the global population, but only a small percentage of infected individuals develop EBV-associated malignancies. Host and viral factors may play a role in determining the clinical outcome.
WANG, JIN-TOWN;SHEEN, TZUNG-SHIAHN;SU, IH-JEN;CHEN, JEN-YANG;CHEN, MEI-RU   +1 more
core  

Serum activity of SOD in EBV-positive, EBV-negative diabetic patients and control group.

open access: yes, 2020
ANOVA Kruskal-Wallis Test (H = 126.92; p < 0.0001; Post-hoc Dunn’s Test: EBV+/EBV- p< 0.0001; EBV+/Control p< 0.0001; EBV-/Control p< 0.0001.
Jakub Dworzański (7423370)   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy